Titlebook: Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3; Basic Science and Cl David A. Sullivan,Michael E. Stern,B. Britt Brombe Book 2002 The E

Cyclone

書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3影響因子(影響力)




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3影響因子(影響力)學(xué)科排名




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3網(wǎng)絡(luò)公開(kāi)度




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3被引頻次




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3被引頻次學(xué)科排名




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3年度引用




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3年度引用學(xué)科排名




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3讀者反饋




書目名稱Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3讀者反饋學(xué)科排名

打算

GDNF Family Signalling in Exocrine Tissues: Distinct Roles for GDNF and Neurturin in Parasympatheticoup in the transforming growth factor-β superfamily. They signal by binding to a receptor complex consisting of a ligand-binding GPI-anchored GDNF family receptor a (GFRα1 to GFRα4) and the trans-membrane tyrosine kinase Ret (for review see references 1–3). A schematic view of the GDNF family signaling is shown in Fig. 1.

Noisome

absolve

引起

Lipase mRNAs Expressed in Lacrimal and Harderian Glandss aqueous evaporation and protects the ocular surface from environmental irritants. The lacrimal glands supply the bulk of the ocular tear fluid phase, as well as many dissolved proteins. The meibomian glands of the eyelid secrete the lipids. Harderian glands of non-primate vertebrates secrete proteins and lipids.

Estimable

破裂

978-1-4613-5208-2The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Busines

Magnitude

一加就噴出

贊美者

ssant. Although these drugs have much toxicity, there is insufficient data to show that CNI-free immunosuppression is safe or feasible from the time of transplantation. Most centers also use an additional adjunctive agent, either in the form of an antimetabolite (azathioprine [AZA] or mycophenolate